Does Brain Training Work? The Evidence, Honestly

Summary

Brain-training companies often promised broad cognitive improvements transferring to school, work, and aging.

The FTC fined Lumosity $2 million in 2016 for deceptive advertising tied to those broad claims.

A Stanford-organised 2014 scientific consensus statement signed by 70+ cognitive scientists warned that many brain-game claims were exaggerated.

Simons et al.'s 2016 review in Psychological Science in the Public Interest surveyed the published evidence and concluded near-transfer is real and far-transfer evidence is weak.

Senwitt avoids the broad-transfer promise structure entirely — practice the skills, keep using the skills.

Why does Senwitt avoid brain-training claims?

Senwitt avoids brain-training claims because the category accumulated a specific kind of risk. Companies marketing "brain training" often promised improvements that would transfer to school, work, athletics, or age-related cognition — and those promises drew regulatory action and scientific pushback. The FTC fined Lumosity $2 million over related deceptive advertising charges in 2016, and a Stanford-organised consensus statement warned that many brain-game claims were exaggerated. Senwitt takes the lesson and makes a smaller, more honest promise: practice the skills you care about, keep using the skills you care about.

The careful reader will notice that "brain training works" and "brain training does not work" are both oversimplified versions of a more interesting answer. Practice on a specific cognitive task does reliably produce improvement on that specific task (near transfer is real). What is contested — and what the FTC, the 2014 Stanford consensus, and the 2016 Simons review all focused on — is whether commercial brain-training products produce far transfer: improvement on untrained tasks or in real-world cognitive performance. That is the boundary the category historically pushed against, and Senwitt sits deliberately on the safe side of it.

What the source says

The FTC's 2016 press release on the Lumosity settlement (FTC press release) is direct: Lumos Labs was charged with deceptive advertising tied to claims that its program could improve performance at school, work, and athletics, delay age-related cognitive impairment, and reduce cognitive impairment associated with health conditions including Alzheimer's disease and ADHD. The settlement required a $2 million payment, required Lumosity to notify auto-renewed subscribers, and required the company to offer cancellation paths to those subscribers.

The Stanford-organised consensus statement (Stanford consensus) was published in 2014 and signed by over seventy cognitive scientists from Stanford, the Max Planck Institute, and other institutions. The statement's core conclusion: "there is little evidence that playing brain games improves underlying broad cognitive abilities, or that it enables one to better navigate a complex realm of everyday life." It specifically targeted the marketing promise of transfer to real-world ability. Science covered the response from the scientific community (Science).

Simons, Boot, Charness, Gathercole, Chabris, Hambrick, and Stine-Morrow published a comprehensive review in 2016 in Psychological Science in the Public Interesttitled "Do Brain-Training Programs Work?" (PMC full text; summary). The review surveyed the published evidence on commercial brain-training products and concluded: practice on a specific task produces improvement on that task (near transfer is robust); evidence for far transfer — improvement on untrained cognitive tasks or in real-world performance — is weak; the strongest evidence for far transfer in the category is the NIH ACTIVE Trial work on speed-of-processing training (which became part of BrainHQ).

The MacNamara & Maitra 2019 partial replication of Ericsson's deliberate practice work in Royal Society Open Science (MacNamara & Maitra) added precision to the underlying practice literature: deliberate practice accounts for a meaningful but smaller portion of skill variance than the popular "10,000 hours" framing implied, and the gains are domain-specific. That is exactly what near-transfer language captures.

What the source does not say

None of these sources claim that all brain games are useless. They claim that the broad-transfer marketing claims were not well supported by the evidence at the time. They do not say that practice has no value. They do say that practice claims should not exceed what the evidence supports.

The 2014 Stanford consensus statement and the 2016 Simons review both explicitly distinguish between research-grade cognitive interventions in controlled settings (which sometimes show real effects) and broad consumer marketing claims (which often did not match the underlying evidence). The FTC action against Lumosity was about the second category, not the first.

None of the sources claim that BrainHQ's speed-of-processing programme is invalid — the NIH-funded ACTIVE Trial is consistently cited in the opposite direction, as the strongest commercial-product evidence in the category. Senwitt does not claim parity with that work and does not need to.

What this means for daily practice

For Senwitt the takeaway is structural. We sell brain exercise, not brain training. We describe the product as daily practice across six Skills, with a simple internal Sharpness rating. We do not claim that completing daily Sets improves school performance, work performance, athletic ability, or age-related cognition. We do not claim cognitive transfer in any direction beyond "practising a skill keeps that skill in regular use."

That is not a marketing weakness. It is a trust signal. The honest version of the offer is the one that holds up over time — and, more practically, it is the version that does not invite the regulatory and scientific response the broader brain-training category drew in the 2010s.

For users specifically interested in interventions with peer-reviewed evidence of real-world transfer, BrainHQ is the right product in the commercial market — see the BrainHQ comparison page for the honest framing.

From Senwitt · advertisement

The text above is editorial. What follows is a promotional message from Senwitt, the maker of this site. Senwitt is a brain-exercise app and is not a medical product. Read the full disclaimer in the footer.

References — canonical order.

1.Kosmyna, N., Hauptmann, E., Yuan, Y.T., Situ, J., Liao, X.-H., Beresnitzky, A.V., Braunstein, I., & Maes, P. (2025). Your Brain on ChatGPT: Accumulation of Cognitive Debt when Using an AI Assistant for Essay Writing Task. arXiv:2506.08872. arxiv.org/abs/2506.08872. Primary anchor.

2.Stanković, M., Hirche, E., Kollatzsch, S., & Doetsch, J.N. (2026). Comment on: Your Brain on ChatGPT. arXiv:2601.00856. arxiv.org/abs/2601.00856. The methodological critique — paired with Kosmyna.

3.Risko, E.F. & Gilbert, S.J. (2016). “Cognitive Offloading.” Trends in Cognitive Sciences 20(9):676–688. DOI: 10.1016/j.tics.2016.07.002.

4.Sparrow, B., Liu, J., & Wegner, D.M. (2011). “Google Effects on Memory: Cognitive Consequences of Having Information at Our Fingertips.” Science 333(6043):776–778. DOI: 10.1126/science.1207745.

5.Simons, D.J., Boot, W.R., Charness, N., Gathercole, S.E., Chabris, C.F., Hambrick, D.Z., et al. (2016). “Do ‘Brain-Training’ Programs Work?” Psychological Science in the Public Interest 17(3):103–186. DOI: 10.1177/1529100616661983.

6.FTC v. Lumos Labs, Inc. (2016). “Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges for Its ‘Brain Training’ Program.” Stipulated $50M judgment, suspended on payment of $2M. ftc.gov press release (Jan 5 2016).

7.Max Planck Institute for Human Development & Stanford Center on Longevity (2014). A Consensus on the Brain Training Industry from the Scientific Community. Signed by 70 neuroscientists/psychologists. longevity.stanford.edu.

Not brain training. Brain exercise.

Senwitt is a daily brain exercise app, not a brain training program. We do not claim to improve general cognition, prevent cognitive decline, or treat any condition. Independent scientific consensus — the 2014 Stanford Center on Longevity / Max Planck Institute statement signed by 70 neuroscientists, the 2016 Simons et al. review in Psychological Science in the Public Interest, and the FTC's 2016 settlement with Lumos Labs — has concluded that “brain training” claims are not supported by the evidence. Senwitt is built on a different premise: skills you actively practice get sharper; skills you stop practicing fade.

Why we avoid old brain-training claims

Why Senwitt does not make old brain-training claims.